Based on evidence from clinical trials, after two doses, the Pfizer-BioNTech COVID-19 vaccine is 90.7% effective in preventing COVID-19 in children ages 5 through 11. No other vaccines are authorized for use in children at this time.
Based on evidence from clinical trials, after two doses, the Pfizer-BioNTech COVID-19 vaccine is 90.7% effective in preventing COVID-19 in children ages 5 through 11. No other vaccines are authorized for use in children at this time.
Comments
0 comments
Please sign in to leave a comment.